Culture Biosciences is thrilled to have Eliana Clark, PhD, Executive Vice President and Chief Technical Officer at Intellia Therapeutics, Inc., join its Advisory Board. This collective of experienced experts will be an immense help to the organization, fostering crucial partnerships and guiding Culture as it strives to expand in the biotechnology and biopharmaceutical realms. Clark’s addition marks a true milestone for the company!
We are thrilled to welcome Eliana onboard to help Culture Biosciences drive innovative solutions to persistent bottlenecks in upstream bioprocess development. By harnessing state-of-the-art technologies like cloud software and data-driven modeling, our team is poised to accelerate the development of new treatments for patients, advancing the development of gene and cell therapies with unprecedented speed.
Eliana Clark is a proven leader in the biopharmaceutical industry, with an impressive track record spanning over 35 years. Her expertise ranges from process optimization and technology development to CMC strategy, regulatory compliance, operations, internal and external manufacturing, and supply chain management. Her strategic acumen and hands-on approach to problem solving sets her apart as an industry leader.
As the Executive Vice President and Chief Technical Officer of Intellia Therapeutics, Inc., Dr. Eliana Clark is eager to join forces with her fellow members of the Culture Biosciences Advisory Board and help usher in an era of innovation in the realm of upstream bioprocess development.
Faster, more reliable ways of scaling processes can revolutionize the realm of bioprocessing and bring new therapies to market faster and more cost-effectively, and Dr. Clark is excited to take part in making this a reality.
More about Eliana Clark
Eliana Clark is no stranger to Intellia, having been the company’s Senior Vice President, Technical Operations and Quality prior to her current role. She brings a wealth of experience to her current post, with previous distinguished roles in Product and Portfolio Management, Manufacturing, Manufacturing Sciences, Process Development and CMC-Regulatory at Biogen and Sanofi/Genzyme. Her expertise makes her a valuable asset to Intellia.
Eliana has made an impressive career journey from academia to industry, starting with her PhD and Bachelor of Engineering degree in Chemical Engineering from the Universidad Nacional del Litoral in Santa Fe, Argentina. She then held postdocs in Biochemical Engineering at the University of Delaware and the Worcester Polytechnic Institute.
She then became a professor at Tufts University in the Chemical and Biological Engineering Department before making the jump into industry. To top it off, Eliana recently graduated from the Greater Boston Executive Program at MIT Sloan.
About Culture Biosciences
Culture Biosciences is a revolutionary company aiming to revolutionize the way upstream bioprocess development is conducted. Working to reduce the costs, time, and resources involved in bioprocessing for therapeutic manufacturing, Culture provides a comprehensive, integrated platform combining bioreactors, cloud-based software, and services for client companies worldwide. Founded in 2016, Culture Biosciences is headquartered in South San Francisco, CA.